The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Calidi Biotherapeutics Inc’s current trading price is -81.66% away from its 52-week high, while its distance from the 52-week low is 251.95%. The stock’s price range for this period has been between $0.20 and $3.89 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 5.97 million for the day, a number notably lower than the average daily volume of 14.0 million over the last three months.
The stock of Calidi Biotherapeutics Inc (CLDI) is currently priced at $0.71. In the last session, the stock climbed significantly, topping out at $10.0 after opening at $0.71. The day’s lowest price was $10.0 before the stock closed at $0.59.
In terms of market performance, Calidi Biotherapeutics Inc had a fairly uneven.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Calidi Biotherapeutics Inc (CLDI) has experienced a quarterly rise of 54.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 24.63M and boasts a workforce of 28 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5129, with a change in price of -0.1379. Similarly, Calidi Biotherapeutics Inc recorded 8,906,644 in trading volume during the last 100 days, posting a change of -16.20%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CLDI stands at 0.68. Similarly, the long-term debt-to-equity ratio is also 0.32.
CLDI Stock Stochastic Average
As of today, Calidi Biotherapeutics Inc’s raw stochastic average for the last 50 days stands at 36.55%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 36.55%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 31.37% and 29.90%, respectively.
CLDI Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -59.92% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -20.34%. Over the past 30 days, the price of CLDI has fallen by 141.83%. And in the last five days, it has surged by 23.21%.
